Glenmark Pharma gets USFDA nod for generic skin inflammation treatment foam Posted By: Unknown February 18, 2019 Leave a Reply The company said its current portfolio consists of 150 products authorised for distribution in the US and 52 ANDA's pending approval with the USFDA from Latest News http://bit.ly/2Ihcz9p https://ift.tt/eA8V8J http://bit.ly/2SdCH5P Tweet Share Share Share Share
0 comments: